It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | Under LiquidationAmra Remedies Limited, a under liquidation public limited company, was established on 23 February 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239MH2011PLC213956. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.06 Cr.
Its leadership includes Manoor Sayed Husain Sayed (Additional Director), Ajit Annu Kamath (Director), Rajendra Padmanabhan Kaimal (Director). Past directors included Manoj Tejraj Jain. It holds ₹48.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at H-Wing, 4Th Floor, Tex Centre,Narayan Properties Chandivali, Off. Saki Vihar Rd., Andher, I (East), Mumbai, Maharashtra, 400072.
U24239MH2011PLC213956
213956
23 February 2011
₹10.00 Cr
₹6.06 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Amra Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoor Sayed Husain Sayed | Additional Director | 14 Jul 2014 | Current |
| Ajit Annu Kamath | Director | 23 Feb 2011 | Current |
| Rajendra Padmanabhan Kaimal | Director | 23 Feb 2011 | Current |
| Sajid Ali Asad Ali Khan | Additional Director | 24 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jul 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amra Remedies Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.09% increase in profit. The company's net worth dipped by a decrease of 1.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Amra Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹485,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2013 | Unilazer Ventures Private Limited | ₹10.00 Cr | Open |
| 31 Oct 2012 | State Bank Of India | ₹23.50 Cr | Open |
| 20 Jan 2012 | Nkgsb Co-Operative Bank Limited | ₹15.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amra Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amra Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amra Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Amra Remedies Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.
The activity Amra Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was completed.
Sajid Ali Asad Ali Khan was appointed as a Additional Director was appointed as a Additional Director on 24 Jun 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
The activity Manoor Sayed Husain Sayed was appointed as a Additional Director was appointed as a Additional Director on 14 Jul 2014 & has been associated with this company since 11 years 4 months . was completed.
Progress on A charge with Unilazer Ventures Private Limited amounted to Rs. 10.00 Cr with Charge ID 10437209 was registered on 15 Jul 2013. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 23.50 Cr with Charge ID 10391106 was registered on 31 Oct 2012. was documented.
The CIN of Amra Remedies Limited is U24239MH2011PLC213956.
Amra Remedies Limited is headquartered at H-Wing, 4Th Floor, Tex Centre,Narayan Properties Chandivali, Off. Saki Vihar Rd., Andher, I (East), Mumbai, Maharashtra, 400072.
Amra Remedies Limited was incorporated on 23 February 2011.
The current directors of Amra Remedies Limited are
The primary industry of Amra Remedies Limited is Pharma.
Amra Remedies Limited is unlisted.
The authorized capital of Amra Remedies Limited is ₹10.00 Cr, and the paid-up capital is ₹6.06 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX